Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-160.63%
operating margin TTM
-507.82%
revenue TTM
151.38 Million
revenue per share TTM
1.5$
valuation ratios | |
|---|---|
| pe ratio | -0.59 |
| peg ratio | -0.01 |
| price to book ratio | -0.12 |
| price to sales ratio | 0.95 |
| enterprise value multiple | -0.04 |
| price fair value | -0.12 |
profitability ratios | |
|---|---|
| gross profit margin | 47.47% |
| operating profit margin | -507.82% |
| pretax profit margin | -517.78% |
| net profit margin | -160.63% |
| return on assets | -22.18% |
| return on equity | 21.44% |
| return on capital employed | -185.2% |
liquidity ratio | |
|---|---|
| current ratio | 1.47 |
| quick ratio | 1.45 |
| cash ratio | 0.38 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 74.01 |
| operating cycle | 431.13 |
| days of payables outstanding | 118.79 |
| cash conversion cycle | 312.35 |
| receivables turnover | 1.02 |
| payables turnover | 3.07 |
| inventory turnover | 4.93 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.34 |
| debt equity ratio | -0.32 |
| long term debt to capitalization | -0.48 |
| total debt to capitalization | -0.48 |
| interest coverage | -15.79 |
| cash flow to debt ratio | -1.89 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.37 |
| cash per share | 0.50 |
| operating cash flow per share | -1.37 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.89 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -518.79 |
Frequently Asked Questions
When was the last time FibroGen, Inc. (NASDAQ:FGEN) reported earnings?
FibroGen, Inc. (FGEN) published its most recent earnings results on 12-11-2024.
What is FibroGen, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. FibroGen, Inc. (NASDAQ:FGEN)'s trailing twelve months ROE is 21.44%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. FibroGen, Inc. (FGEN) currently has a ROA of -22.18%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did FGEN's net profit margin stand at?
FGEN reported a profit margin of -160.63% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is FGEN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.47 in the most recent quarter. The quick ratio stood at 1.45, with a Debt/Eq ratio of -0.32.